Cargando…

Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014

The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from patients admitted to an Italian university hospital...

Descripción completa

Detalles Bibliográficos
Autores principales: Lovero, Grazia, Borghi, Elisa, Balbino, Stella, Cirasola, Daniela, De Giglio, Osvalda, Perdoni, Federica, Caggiano, Giuseppina, Morace, Giulia, Montagna, Maria Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769087/
https://www.ncbi.nlm.nih.gov/pubmed/26919294
http://dx.doi.org/10.1371/journal.pone.0150218
_version_ 1782418052354146304
author Lovero, Grazia
Borghi, Elisa
Balbino, Stella
Cirasola, Daniela
De Giglio, Osvalda
Perdoni, Federica
Caggiano, Giuseppina
Morace, Giulia
Montagna, Maria Teresa
author_facet Lovero, Grazia
Borghi, Elisa
Balbino, Stella
Cirasola, Daniela
De Giglio, Osvalda
Perdoni, Federica
Caggiano, Giuseppina
Morace, Giulia
Montagna, Maria Teresa
author_sort Lovero, Grazia
collection PubMed
description The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from patients admitted to an Italian university hospital from 2007 to 2014. Molecular identification of cryptic species of the C. parapsilosis complex was performed using polymerase chain reaction amplification of the gene encoding secondary alcohol dehydrogenase, followed by digestion with the restriction enzyme BanI. Minimum inhibitory concentrations were determined using the broth microdilution method according to European Committee for Antimicrobial Susceptibility Testing (EUCAST EDef 7.2) and Clinical Laboratory Standards Institute (CLSI M27-A3) guidelines, and the results were compared with those obtained using the E-test and Sensititre methods. Of the 163 C. parapsilosis complex isolates, 136 (83.4%) were identified as C. parapsilosis, and 27 (16.6%) as C. orthopsilosis. The species-specific incidences were 2.9/10,000 admissions for C. parapsilosis and 0.6/10,000 admissions for C. orthopsilosis. No resistance to echinocandins was detected with any of the methods. The percent essential agreement (EA) between the EUCAST and E-test/Sensititre methods for anidulafungin, caspofungin, and micafungin susceptibility was, respectively, as follows: C. parapsilosis, 95.6/97.8, 98.5/88.2, and 93.4/96.3; C. orthopsilosis, 92.6/92.6, 96.3/77.8, and 63.0/66.7. The EA between the CLSI and E-test/Sensititre methods was, respectively, as follows: C. parapsilosis, 99.3/100, 98.5/89.0, and 96.3/98.5; C. orthopsilosis, 96.3/92.6, 100/81.5, and 92.6/88.9. Only minor discrepancies, ranging from 16.9% (C. parapsilosis) to 11.1% (C. orthopsilosis), were observed between the CLSI and E-test/Sensititre methods. In conclusion, this epidemiologic study shows a typical C. parapsilosis complex species distribution, no echinocandin resistance, and it reinforces the relevance of using commercially available microbiological methods to assess antifungal susceptibility. These data improve our knowledge of the national distribution of species of the psilosis group, as there are very few studies of these species in Italy.
format Online
Article
Text
id pubmed-4769087
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-47690872016-03-09 Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014 Lovero, Grazia Borghi, Elisa Balbino, Stella Cirasola, Daniela De Giglio, Osvalda Perdoni, Federica Caggiano, Giuseppina Morace, Giulia Montagna, Maria Teresa PLoS One Research Article The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from patients admitted to an Italian university hospital from 2007 to 2014. Molecular identification of cryptic species of the C. parapsilosis complex was performed using polymerase chain reaction amplification of the gene encoding secondary alcohol dehydrogenase, followed by digestion with the restriction enzyme BanI. Minimum inhibitory concentrations were determined using the broth microdilution method according to European Committee for Antimicrobial Susceptibility Testing (EUCAST EDef 7.2) and Clinical Laboratory Standards Institute (CLSI M27-A3) guidelines, and the results were compared with those obtained using the E-test and Sensititre methods. Of the 163 C. parapsilosis complex isolates, 136 (83.4%) were identified as C. parapsilosis, and 27 (16.6%) as C. orthopsilosis. The species-specific incidences were 2.9/10,000 admissions for C. parapsilosis and 0.6/10,000 admissions for C. orthopsilosis. No resistance to echinocandins was detected with any of the methods. The percent essential agreement (EA) between the EUCAST and E-test/Sensititre methods for anidulafungin, caspofungin, and micafungin susceptibility was, respectively, as follows: C. parapsilosis, 95.6/97.8, 98.5/88.2, and 93.4/96.3; C. orthopsilosis, 92.6/92.6, 96.3/77.8, and 63.0/66.7. The EA between the CLSI and E-test/Sensititre methods was, respectively, as follows: C. parapsilosis, 99.3/100, 98.5/89.0, and 96.3/98.5; C. orthopsilosis, 96.3/92.6, 100/81.5, and 92.6/88.9. Only minor discrepancies, ranging from 16.9% (C. parapsilosis) to 11.1% (C. orthopsilosis), were observed between the CLSI and E-test/Sensititre methods. In conclusion, this epidemiologic study shows a typical C. parapsilosis complex species distribution, no echinocandin resistance, and it reinforces the relevance of using commercially available microbiological methods to assess antifungal susceptibility. These data improve our knowledge of the national distribution of species of the psilosis group, as there are very few studies of these species in Italy. Public Library of Science 2016-02-26 /pmc/articles/PMC4769087/ /pubmed/26919294 http://dx.doi.org/10.1371/journal.pone.0150218 Text en © 2016 Lovero et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lovero, Grazia
Borghi, Elisa
Balbino, Stella
Cirasola, Daniela
De Giglio, Osvalda
Perdoni, Federica
Caggiano, Giuseppina
Morace, Giulia
Montagna, Maria Teresa
Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title_full Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title_fullStr Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title_full_unstemmed Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title_short Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007–2014
title_sort molecular identification and echinocandin susceptibility of candida parapsilosis complex bloodstream isolates in italy, 2007–2014
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769087/
https://www.ncbi.nlm.nih.gov/pubmed/26919294
http://dx.doi.org/10.1371/journal.pone.0150218
work_keys_str_mv AT loverograzia molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT borghielisa molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT balbinostella molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT cirasoladaniela molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT degiglioosvalda molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT perdonifederica molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT caggianogiuseppina molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT moracegiulia molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014
AT montagnamariateresa molecularidentificationandechinocandinsusceptibilityofcandidaparapsilosiscomplexbloodstreamisolatesinitaly20072014